Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
New discovery transforms conventional microfluidics into open-space microfluidics

New discovery transforms conventional microfluidics into open-space microfluidics

FROM CONVENTIONAL MICROFLUIDICS TO OPEN-SPACE MICROFLUIDICS

Microfluidics refers to the manipulation of fluids in microscale devices. Commonly called “labs on a chip,” microfluidic systems are used to study and analyze very small-scale chemical or biological samples, replacing the extremely expensive and cumbersome instruments used for traditional biological analyses. Listed in 2001 among the “10 Emerging Technologies That Will Change the World” by the MIT Technology Review, microfluidics is considered just as revolutionary for biology and chemistry as microprocessors have been to electronics and IT, and it applies to a huge market.

Today, this young discipline, which began to take off in the 2000s with closed systems made up of microchannel networks, is itself being radically transformed by the discovery made by the group of researchers from Polytechnique and McGill University, which reinforces the theoretical and experimental foundations of open-space microfluidics.

This technology, which eliminates channels, competes favourably with conventional microfluidics for certain types of analyses. Indeed, the classical configuration of closed-channel microfluidic devices provides several disadvantages: the scale of the channel cross-sections increases the stress that cells undergo when they are culture; and they are not compatible with the cell-culture standard, the Petri dish, which makes it hard for the industry to adopt it.

The new approach explored by Polytechnique and McGill University researchers is based on microfluidic multipoles (MFMs), a system of simultaneous fluid suction and aspiration through opposing micro-openings on a very small surface placed in a confined space that is less than 0.1 mm thick. “When they come into contact with one another, these jets of fluid form patterns that can be seen by dyeing them with chemical reagents,” says Professor Gervais. “We wanted to understand these patterns while developing a reliable method for modelling MFMs.”

ELEGANT VISUAL SYMMETRY REMINISCENT OF THE WORK OF ARTIST M. C. ESCHER

To understand these patterns, Professor Gervais’s team had to develop a new mathematical model for open multipolar flows. This model is based on a classical branch of mathematics known as conformal mapping that solves a problem related to a complex geometry by reducing it to a simpler geometry (and vice-versa).

PhD student Étienne Boulais first developed a model to study microjet collisions in a multifluidic dipole (an MFM with only two openings), and then, relying on this mathematical theory, extrapolated the model to MFMs with multiple openings. “We can make an analogy with a game of chess in which there is a version with four players, then six or eight, applying a spatial deformation while maintaining the same rules of the game,” he explains.

“When subjected to conformal mapping, the patterns created by fluid jet collisions form symmetrical images reminiscent of the paintings of Dutch artist M.C. Escher,” adds the young researcher, who has a passion for visual arts. “But far beyond its aesthetic appeal, our model allows us to describe the speed with which molecules move through fluids as well as their concentration. We have defined valid rules for all possible systems configurations of up to 12 poles in order to generate a wide variety of flow and diffusion patterns.”

The method is therefore a complete toolbox that will not only make it possible to model and explain the phenomena occurring in MFMs, but also explore new configurations. Thanks to this method, it is now possible to automate open-space microfluidic tests, which up until now have only ever been explored through trial and error.

FABRICATION OF THE DEVICE USING 3D PRINTING

The design and manufacture of the MFM device was accomplished by Pierre-Alexandre Goyette. This device is a small probe made out of resin using a low-cost 3D printing process and connected to a system of pumps and injectors.

“The expertise of Professor Juncker’s team in the detection of proteins by antibodies immobilized on a surface has been invaluable in managing the biological aspects of this project,” says the PhD student in biomedical engineering. “The results obtained with assays validated the accuracy of the models developed by my colleague Étienne.”

The device allows for the simultaneous use of several reagents to detect various molecules in the same sample, which saves biologists valuable time. For certain types of tests, the analysis time could be reduced from several days to a few hours, or even a matter of minutes. In addition, the versatility of this technology should make it usable for various analytical processes, including immunological and DNA tests.

TOWARD A MICROFLUIDIC DISPLAY?

Professor Gervais’s team is already considering a next step in his project: the development of a screen displaying a chemical image.

“It would be a sort of chemical equivalent of the liquid-crystal display,” Professor Gervais explains. “In the same way that we move electrons across a screen, we would send jets of fluid at various concentrations that would react with a surface. Together, they would form an image. We are very excited to move forward with this project, for which we have obtained a provisional patent.”

REINVENTION OF DIAGNOSTIC PROCEDURES AND MEDICAL-TREATMENT FOLLOW-UP

For now, the technology developed by this research team is aimed at the fundamental research market. “Our processes make it possible to expose cells to many reagents simultaneously,” Professor Gervais says. “They can help biologists study the interactions between proteins and reagents on a large scale, increasing the amount and quality of information obtained during assays.”

He explains that subsequently, the pharmaceutical market will also be able to benefit from new methods of screening-system automation resulting from the discovery. Lastly, it opens up a new avenue for drug discovery by facilitating patient cell culture and exposure to various drug agents to determine which ones they respond to best.

Tagged with:

About author

Related Articles